Strength of Statistical Evidence for the Efficacy of Cancer Drugs: A Bayesian Re-Analysis of Randomized Trials Supporting FDA Approval

Merle-Marie Pittelkow, Maximilian Linde, Ymkje Anna de Vries, Lars G. Hemkens, Andreas M. Schmitt, Rob R. Meijer, Don van Ravenzwaaij
doi: https://doi.org/10.1101/2023.06.30.23292074

Data Availability

The data that support the findings of this study are available from https://ceit-cancer.org/ and the OSF framework (https://osf.io/4uhz7).

https://ceit-cancer.org/

https://osf.io/4uhz7

Back to top
Posted July 10, 2024.
Download PDF
Data/Code
Email
Strength of Statistical Evidence for the Efficacy of Cancer Drugs: A Bayesian Re-Analysis of Randomized Trials Supporting FDA Approval
Merle-Marie Pittelkow, Maximilian Linde, Ymkje Anna de Vries, Lars G. Hemkens, Andreas M. Schmitt, Rob R. Meijer, Don van Ravenzwaaij
medRxiv 2023.06.30.23292074; doi: https://doi.org/10.1101/2023.06.30.23292074
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area